Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 7/20 | 0.58 |
| ▸ | MEN1 | O00255 | 2/20 | 0.57 |
| ▸ | NPC1 | O15118 | 2/20 | 0.57 |
| ▸ | RAB9A | P51151 | 2/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.57 |
| ▸ | FLT3 | P36888 | 4/20 | 0.56 |
| ▸ | PDGFRB | P09619 | 2/20 | 0.56 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.51 |
| ▸ | PDGFRA | P16234 | 1/20 | 0.48 |
| ▸ | GPR183 | P32249 | 1/20 | 0.47 |
| ▸ | F7 | P08709 | 1/20 | 0.45 |
| ▸ | F3 | P13726 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6170035 | 0.91 | MEN1 (0.63) | ALOX15MEN1NPC1RAB9AKMT2A | |
| SCHEMBL6169053 | 0.85 | GPR183 (0.58) | ALOX15MEN1NPC1RAB9AKMT2A | |
| SCHEMBL6171786 | 0.85 | MEN1 (0.57) | ALOX15MEN1NPC1RAB9AKMT2A | |
| SCHEMBL6170605 | 0.85 | MEN1 (0.78) | ALOX15MEN1NPC1RAB9AKMT2A | |
| SCHEMBL6170060 | 0.85 | MEN1 (0.57) | ALOX15MEN1NPC1RAB9AKMT2A | |
| SCHEMBL6169285 | 0.82 | RAB9A (0.65) | MEN1NPC1RAB9AKMT2AFLT3 | |
| SCHEMBL6171801 | 0.82 | ALOX15 (0.55) | ALOX15MEN1NPC1RAB9AKMT2A | |
| SCHEMBL6171399 | 0.82 | MEN1 (0.53) | ALOX15MEN1NPC1RAB9AKMT2A | |
| SCHEMBL6172428 | 0.81 | MEN1 (0.62) | ALOX15MEN1NPC1RAB9AKMT2A | |
| SCHEMBL5716749 | 0.80 | PDGFRB (0.72) | MEN1NPC1RAB9AKMT2AFLT3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1045833-B1 | 2,3-SUBSTITUTED INDOLE COMPOUNDS AS COX-2 INHIBITORS | PFIZER (US) | 2005-11-02 | — | — | EP | disclosed |
| US-6608070-B1 | Useful for treatment of medical condition in which prostaglandins are implicated as pathogens | NAKAO KAZUNARI (JP) | 2003-08-19 | — | — | US | disclosed |
| CN-1284064-A | 2,3-substituted indole compounds as cox-2 inhibitors | PFIZER PHARMA (US) | 2001-02-14 | — | — | CN | disclosed |
| EP-1045833-A1 | 2,3-SUBSTITUTED INDOLE COMPOUNDS AS COX-2 INHIBITORS | PFIZER INC. (US) | 2000-10-25 | — | — | EP | disclosed |
| WO-1999035130-A1 | 2,3-SUBSTITUTED INDOLE COMPOUNDS AS COX-2 INHIBITORS | PFIZER PHARMACEUTICALS INC. (JP) | 1999-07-15 | — | — | WO | disclosed |